 |
인쇄하기
취소
|
Dong-A to conduct phase 3 study for Zydena in US
Dong-A Pharmaceutical Co., says it will carry out its Phase 3 multicenter study in the United States, designed to investigate the efficacy and safety of Zydena (udenafil) in 1,120 patients with erectile dysfunction after completing Phase II.
"We are extremely pleased with the results of this 340 patient phase 2b clinical trial in the U.S., which clearly demonstrated an excellent efficacy and...
"We are extremely pleased with the results of this 340 patient phase 2b clinical trial in the U.S., which clearly demonstrated an excellent efficacy and...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.